Skip to Main Content

ACR DSI participates on Panel at AI Health Law and Policy Summit

May 23, 2023
ACR Vice President of Data Science and Informatics Laura Coombs spoke on a panel at the AI Health Law & Policy Summit held in Washington, D.C., on May 18, 2023.  

The summit, presented by global law firm Hogan Lovells, gathered thought leaders and industry guests to address a variety of topics including new and emerging health care artificial intelligence (AI) policies and regulatory considerations, implications for ethics and consumer safety, and developments in the EU. 

Coombs spoke on the "Regulating Evolving AI Technologies” panel alongside colleagues Dr. John J. Smith, a partner at Hogan Lovells, and Sonja Fulmer, Assistant Director for Digital Health Policy at the U.S. Food & Drug Administration. The panel was moderated by Suzanne Levy Friedman, counsel at Hogan Lovells. 

Other panels at the summit included Market Access Landscape – Coding, Coverage and Payment; AI Data Privacy; AI & Public Policy – How to Safeguard and Incentivize Innovation; and AI Dealmaking: Launching AI Products, Negotiating AI Agreements, and Completing AI Transactions. 

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more

  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more

  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more